权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Wnt5a/Ror2 Signaling in Jaw Bone Development

颌骨发育中的 Wnt5a/Ror2 信号转导

基本信息

批准号：
10730208
负责人：
Erin Ealba Bumann
金额：
$ 3.22万
依托单位：
UNIVERSITY OF MISSOURI KANSAS CITY
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-01-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10730208
关键词：
Address Affect Animals Automobile Driving Birds Bone Development Bone Growth Bone Regeneration Bone Resorption Bone Resorption Inhibition Bone Resorption Stimulation Breathing Ca(2+)-Calmodulin Dependent Protein Kinase Calcium Cell Line Cells Cephalic Complex Congenital Abnormality Craniofacial Abnormalities Data Defect Deposition Development Disease Disparity Distraction Osteogenesis Ducks Elements Embryo Endowment Enzymes Event Face Family member Future Gene Expression Gene Expression Profiling Genes Goals Growth and Development function Human Hyperplasia Inhibition of Matrix Metalloproteinases Pathway Injury Intervention Jaw Knowledge Laboratories MMP9 gene Mandible Mastication Maxilla Mediating Molecular Mus Mutation Neural Crest Operative Surgical Procedures Orphan Osteoblasts Osteoclasts Osteocytes Pattern Play Population Procedures Process Quail Quality of life Receptor Protein-Tyrosine Kinases Regulation Robinow syndrome Role Shapes Signal Induction Signal Transduction Skeleton Structure TRANCE protein Techniques Testing Tissues Transplantation Transplantation Chimera Tumor necrosis factor receptor 11b Western Blotting Work bisphosphonate bone calmodulin-dependent protein kinase II cathepsin K cell type collagenase 3 craniofacial development craniofacial structure face bone structure gain of function genetic technology in vivo knock-down knowledge base long bone loss of function malformation member multiphoton microscopy novel novel therapeutics osteogenic overexpression planar cell polarity prevent programs receptor repaired tomography transplant model treatment strategy

项目摘要

PROJECT SUMMARY Our long-term goal is to discover novel molecular-based therapies for regulating the size of bone as a means to address the need for non-surgical treatments of craniofacial malformations. Little is known regarding the precise molecular mechanisms controlling jaw size during growth and development. This lack of knowledge leaves distraction osteogenesis as one of the few available interventions to change jaw size, even though bones of the face are known to be much more difficult to manipulate with this technique than long bones. Procedures to treat jaw size disparities will greatly benefit from a broader knowledge base of molecular and cellular mechanisms that control jaw size. The objective of the current study is to build toward this goal by understanding how the cranial neural crest (CNC), which forms all the elements in the facial and jaw skeletons, regulates jaw size. To address this issue, we propose to manipulate in vivo the CNC, a highly accessible embryonic population. For example, we can transplant quail donor CNC into a duck host, which creates a chimeric quck; and we transplant duck donor CNC into the quail host, generating chimeric duail. Exploiting the divergent developmental programs of quail and duck provides a unique way to manipulate signaling between CNC and adjacent host tissues and allows discovery of CNC-dependent processes. Some groups have looked at bone deposition in controlling jaw size, but our data suggest that bone resorption by mesodermally-derived osteoclasts with participation of CNC- derived osteocytes control jaw size at later stages of development. We have previously shown that CNC controls jaw size, bone resorption is controlled by CNC and that bone resorption controls jaw size. How CNC accomplishes such a complex task, and what factors are sufficient to replicate this phenomenon, is unknown. Likely candidates may include members and targets of WNT5A/ROR2 noncanonical signaling, since they are known to play critical roles during bone resorption. Therefore, we hypothesize that by modulating WNT5A/ROR2 non-canonical signaling, CNC directs bone resorption to control jaw bone size. To test our hypothesis, we propose two complementary and highly translational Specific Aims. Specific Aim 1 will determine the mechanism by which CNC-derived osteocytes and mesodermally-derived osteoclasts act via WNT5A/ROR2 non-canonical signaling to resorb bone and regulate jaw bone size. Specific Aim 2 will determine the mechanism via which CNC acts by WNT5A/ROR2 noncanonical signaling to regulate the actions of osteoclast-mediated bone resorption to regulate jaw bone size. We will employ gain- and loss-of-function techniques to identify molecular mechanisms that endow CNC with the ability to control mandibular bone development. By determining the precise mechanism of control of bone resorption by osteoclasts and osteocytes, future studies will be able to develop accurate therapies to control lower jaw bone development.

项目总结

项目成果

期刊论文数量（1）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Treatment with an inhibitor of matrix metalloproteinase 9 or cathepsin K lengthens embryonic lower jaw bone.

使用基质金属蛋白酶 9 或组织蛋白酶 K 抑制剂进行治疗可延长胚胎下颌骨。

DOI：
10.1111/ocr.12635
发表时间：
2023
期刊：
Orthodontics & craniofacial research
影响因子：
3.1
作者：
Houchen,ClaireJ;Castro,Bethany;HahnLeat,Portia;Mohammad,Nashwa;Hall-Glenn,Faith;Bumann,ErinE
通讯作者：
Bumann,ErinE